Elevated Levels of Circulating Fibroblast Growth Factor 23 With Hypercalcemia Following Discontinuation of Denosumab
Endocrine Journal - Japan
doi 10.1507/endocrj.ej19-0198
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2020
Authors
Publisher
Japan Endocrine Society